Safer transfusions, better patient care. That’s our mission.

New Health Sciences seeks to bring about radical improvements in patient care through the acquisition, development, and commercialization of innovative technologies in transfusion medicine.

Spotlight

Quality Engineer New Health Sciences Awarded $3 Million NIH Grant to Commercialize Hemanext®

New Health Sciences, Inc. (NHSi), a medical technology company focused on innovations that improve transfusion therapy, today announced today that it has been awarded an SBIR Phase IIB Bridge Grant by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH).  The award provides $3 million in funding over 3 years to complete the product development and clinical work required to commercialize Hemanext®, NHSi’s novel gas optimized storage system for donated red blood cells.

Read More >

News

New Health Sciences Awarded $3 Million NIH Grant to Commercialize Hemanext®

April 27th, 2016|Comments Off on New Health Sciences Awarded $3 Million NIH Grant to Commercialize Hemanext®

Bethesda, MD – April 27, 2016 – New Health Sciences, Inc. (NHSi), […]

Industry Sponsor of the BEST Collaborative

April 18th, 2016|Comments Off on Industry Sponsor of the BEST Collaborative

New Health Sciences has just returned from the Spring 2016 meeting of […]

Read All News >